Changes in immune cell frequencies after cyclophosphamide or ...
Recommend Documents
Feb 7, 2011 - Immune Recovery after Cyclophosphamide Treatment in Multiple. Myeloma: Implication for Maintenance Immunotherapy. Amir Sharabi1, 2 and ...
Jun 16, 1971 - The thymus macrophages behaviour during cyclophosphamide induced thymic lympholysis has been studied in the mouse previously injected.
Apr 1, 2015 - performed by Polygene (Switzerland) and four founder animals per ...... Westerlund M, Belin AC, Anvret A, Bickford P, Olson L, Galter D (2008) ...
Oct 14, 2010 - Immune reconstitution after haploidentical hematopoietic cell transplantation: impact of reduced intensity conditioning and CD3/CD19 depleted ...
Natural killer cell. T cell. a b s t r a c t. Haploidentical hematopoietic stem cell transplantation ...... 15eactivated cytokine-induced killer cells to treat relapse.
Nov 17, 2016 - Keywords: hematopoietic stem cell transplantation, immune ... transplant (BMT) and peripheral blood stem cell transplant (PBSCT), what ...
Oct 14, 2010 - thiotepa, fludarabine and anti-thymocyte globulin was used to eliminate the recipient T cells. The strategy allowed successful. HHCT with a low ...
Oct 20, 2010 - Age related changes in T cell mediated immune response and effector memory to Respiratory. Syncytial Virus (RSV) in healthy subjects.
Antonín DREISEITL. Agrotest Fyto Ltd., Kroměříž, Czech Republic. Abstract. Dreiseitl A. (2015): .... Praha–Plzeň. 80. L. Praha–Petrohrad. 75. M. Praha–Lovosice.
Stroke is a leading cause of human death and disability in the USA and around the world. Shortly after the cerebral ischemia, cell swelling is the earliest ...
Feb 18, 2011 - Abstract. Background Systemic lupus erythematosus (SLE) often requires administration of cyclophosphamide (CYC), espe- cially for severe ...
cell changes after Ahmed valve and Molteno glaucoma im- plants. Ophthalmic Surg Lasers Imaging 2011;42:394-9. 17. Kalinina Ayuso V, Scheerlinck LM, ...
variously impacts corneal endothelial cell characteristics in eyes undergoing uneventful ... and faster alternative in experienced hands without generating higher ECD loss rates. ... coemulsification maneuver due to suppression of free radi-.
and 21 days after cryptorchidism, an enhanced testosterone response was observed ... Bilateral cryptorchidism also results in some degree of Leydig cell failure.
Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene status.
Accelerated (dose-dense) chemotherapy, in which the frequency of administration is increased ... neoadjuvant or adjuvant chemotherapy for early breast cancer.
Micronucleus frequencies in Astyanax bimaculatus (Characidae) treated with cyclophosphamide or vinblastine sulfate. F.E. Matsumoto and I.M.S. Cólus.
Dec 18, 1989 - Effects of Interleukin-3 on Hematopoietic Recovery after 5-Fluorouracil ... sults indicate that the administration of rhIL-3 following in- ... tained according to National Institutes of Health (NIH) guidelines for the use and care of .
Oct 22, 2018 - Diabetes Research Foundation (2-SRA-2016-288-S-B, 1-PNF- ..... Harley J, Chen X, Pujato M, Miller D, Maddox A, Forney C, et al.
114. DOSE PRECISION USING A PRETRANSPLANT TEST PK OF INTRAVENOUS. BUSULFAN PRIOR TO BuCyVP-16 PREPARATIVE REGIMEN IN.
Feb 27, 2014 - To investigate the characteristics of immune cells .... patients in the 3 groups on the 14th day of the menstrual cycle and immune cells were.
http://dx.doi.org/10.1155/2013/903094. Case Report. Cell Based Autologous Immune Enhancement. Therapy (AIET) after Radiotherapy in a Locally Advanced.
Aug 10, 2007 - Abstract Autologous stem cell transplantation (ASCT) to ... response toward the vaccination antigens after ASCT. Keyword .... Anti-TNF-α anti-tumor necrosis factor alpha therapy, AURO auromyosine, AZA azathioprine, CsA cyclosporine A,
Changes in immune cell frequencies after cyclophosphamide or ...
Feb 21, 2012 - ORIGINAL ARTICLE. Changes in immune cell frequencies after cyclophosphamide or mycophenolate mofetil treatments in patients.
Clin Rheumatol (2012) 31:951–959 DOI 10.1007/s10067-012-1958-8
ORIGINAL ARTICLE
Changes in immune cell frequencies after cyclophosphamide or mycophenolate mofetil treatments in patients with systemic lupus erythematosus Ling Zhao & Zhenyu Jiang & Yanfang Jiang & Ning Ma & Kai Wang & Yandong Zhang
Received: 19 October 2011 / Revised: 29 December 2011 / Accepted: 2 February 2012 / Published online: 21 February 2012 # Clinical Rheumatology 2012
Abstract This study was designed to explore the profile of immune cell subsets, including T, B, natural killer (NK), and NKT cells, in systemic lupus erythematosus (SLE) patients, and to determine their relationships with the clinical index and the effects of cyclophosphamide (CYC) and mycophenolate mofetil (MMF) treatment. SLE patients (n028) and age/sex-matched healthy controls (n028) were evaluated. The patients were equally divided into two treatment groups: intravenous drip (IVD) with CYC and prednisolone, and oral MMF and IVD with prednisolone. SLE peripheral blood samples were taken immediately prior to treatment and after 4 weeks of drug treatment. T, B, NK, and NKT cell subsets were measured by flow cytometry. Double-stranded DNA antibody and Sm antibody were detected by indirect immunofluorescence. Serum C3, C4, and C-reactive protein were determined by scatter turbidimetry. The percentages of CD3+CD4+ T, CD3–CD16CD56+ NK, and CD3 +CD16CD56+ NKT cells and the CD4+/CD8+ ratio were
significantly lower in SLE patients, while CD3+CD8+ T and CD3–CD19+ B cells were higher than the controls. The lymphocyte subsets were significantly correlated with the SLE disease activity index (SLEDAI) and complement factors (C3, C4). Four weeks of CYC or MMF treatment led to a significant increase in CD3+CD4+ T cells (P
